Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Athanassia Sergounioti"'
Autor:
Theodoros Karakonstantakis, Ioannis Papassotiriou, Maria Theodoridou, Kalliopi Theodoridou, Athanassia Sergounioti, Maria Giannaki, Panayiotis Moraitis, Despoina Afordakou
Publikováno v:
Interventional Medicine and Applied Science. 4:15-20
Objectives: To investigate and assess selenium (Se) and zinc (Zn) serum alterations in children with acute infections. Material and Methods: We determined Se, Zn, C-reactive protein (CRP), serum amyloid A (SAA), and procalcitonin (PCT) in 80 children
Autor:
Polyxeni Delaporta, Evgenios Goussetis, Ioannis Papassotiriou, Athanassia Sergounioti, Alexandra Margeli, Eugenia Hantzi, Vassilios Ladis, Antonis Kattamis
Publikováno v:
Blood Cells, Molecules, and Diseases. 44:152-155
Deferasirox (Exjade®) is a once-daily, oral iron chelator approved for the treatment of transfusional iron overload. This study was conducted to analyze changes in cystatin C concentration, an endogenous marker of glomerular filtration rate (GFR), i
Autor:
Athanassia Sergounioti, Polyxeni Delaporta, Ioannis Papassotiriou, Eugenia Hantzi, Antonios Kattamis, Vassilios Ladis, Alexandra Margeli
Publikováno v:
Blood. 112:5419-5419
Deferasirox (Exjade®, ICL670) is an once-daily, oral iron chelator for the treatment of transfusional iron overload and its efficacy and tolerability have been established in adults and children with a range of transfusion-dependent anemias, such as